Zydus Lifesciences Limited (ZYDUSLIFE.NS)
INR 883.15
(1.65%)
INR 883.15
(1.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 125.21 Billion INR | 21.06% |
| 2022 | 105.67 Billion INR | 17.31% |
| 2021 | 90.08 Billion INR | -3.56% |
| 2020 | 93.41 Billion INR | 7.84% |
| 2019 | 86.62 Billion INR | 11.08% |
| 2018 | 77.98 Billion INR | 7.47% |
| 2017 | 72.56 Billion INR | 25.26% |
| 2016 | 57.93 Billion INR | -9.16% |
| 2015 | 63.77 Billion INR | 19.4% |
| 2014 | 53.41 Billion INR | 21.32% |
| 2013 | 44.02 Billion INR | 11.48% |
| 2012 | 39.49 Billion INR | 30.15% |
| 2011 | 30.34 Billion INR | 1.51% |
| 2010 | 29.89 Billion INR | 19.17% |
| 2009 | 25.08 Billion INR | 31.62% |
| 2008 | 19.05 Billion INR | 29.15% |
| 2007 | 14.75 Billion INR | 28.51% |
| 2006 | 11.48 Billion INR | 31.01% |
| 2005 | 8.76 Billion INR | 15.48% |
| 2004 | 7.59 Billion INR | 9.13% |
| 2003 | 6.95 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 35.22 Billion INR | -6.19% |
| 2023 Q1 | 33.78 Billion INR | 7.03% |
| 2023 FY | 127.93 Billion INR | 21.06% |
| 2023 Q2 | 27.84 Billion INR | -17.57% |
| 2023 Q3 | 28.75 Billion INR | 3.25% |
| 2023 Q4 | 37.54 Billion INR | 30.6% |
| 2022 Q1 | 24.13 Billion INR | 22.87% |
| 2022 FY | 105.67 Billion INR | 17.31% |
| 2022 Q2 | 23.48 Billion INR | -2.71% |
| 2022 Q3 | 26.49 Billion INR | 12.83% |
| 2022 Q4 | 31.56 Billion INR | 19.14% |
| 2021 Q2 | 23.04 Billion INR | -9.36% |
| 2021 Q4 | 19.64 Billion INR | -10.6% |
| 2021 FY | 90.08 Billion INR | -3.56% |
| 2021 Q1 | 25.42 Billion INR | 18.69% |
| 2021 Q3 | 21.97 Billion INR | -4.67% |
| 2020 Q3 | 24.6 Billion INR | 0.83% |
| 2020 Q1 | 23.89 Billion INR | 31.15% |
| 2020 Q4 | 21.42 Billion INR | -12.92% |
| 2020 FY | 93.41 Billion INR | 7.84% |
| 2020 Q2 | 24.4 Billion INR | 2.11% |
| 2019 Q4 | 18.22 Billion INR | -23.89% |
| 2019 FY | 86.62 Billion INR | 11.08% |
| 2019 Q1 | 22.36 Billion INR | 31.86% |
| 2019 Q3 | 23.93 Billion INR | 8.31% |
| 2019 Q2 | 22.1 Billion INR | -1.19% |
| 2018 Q3 | 22.25 Billion INR | 13.02% |
| 2018 Q1 | 19.07 Billion INR | -11.99% |
| 2018 FY | 77.98 Billion INR | 7.47% |
| 2018 Q4 | 16.96 Billion INR | -23.78% |
| 2018 Q2 | 19.69 Billion INR | 3.26% |
| 2017 Q2 | 21.33 Billion INR | 55.95% |
| 2017 FY | 72.56 Billion INR | 25.26% |
| 2017 Q4 | 21.66 Billion INR | 1.49% |
| 2017 Q3 | 21.35 Billion INR | 0.08% |
| 2017 Q1 | 13.67 Billion INR | -11.74% |
| 2016 FY | 57.93 Billion INR | -9.16% |
| 2016 Q1 | 14.42 Billion INR | -7.33% |
| 2016 Q2 | 14.93 Billion INR | 3.52% |
| 2016 Q3 | 13.5 Billion INR | -9.57% |
| 2016 Q4 | 15.49 Billion INR | 14.78% |
| 2015 FY | 63.77 Billion INR | 19.4% |
| 2015 Q4 | 15.56 Billion INR | 0.92% |
| 2015 Q3 | 15.42 Billion INR | -1.6% |
| 2015 Q2 | 15.67 Billion INR | 2.41% |
| 2015 Q1 | 15.3 Billion INR | 2.52% |
| 2014 Q3 | 14 Billion INR | 12.81% |
| 2014 Q2 | 12.41 Billion INR | 2.85% |
| 2014 Q1 | 12.07 Billion INR | 1.0% |
| 2014 FY | 53.41 Billion INR | 21.32% |
| 2014 Q4 | 14.92 Billion INR | 6.59% |
| 2013 Q2 | 10.22 Billion INR | -4.31% |
| 2013 Q1 | 10.68 Billion INR | 29.37% |
| 2013 Q3 | 11.17 Billion INR | 9.36% |
| 2013 Q4 | 11.95 Billion INR | 6.93% |
| 2013 FY | 44.02 Billion INR | 11.48% |
| 2012 Q4 | 8.25 Billion INR | -22.56% |
| 2012 Q3 | 10.66 Billion INR | -31.5% |
| 2012 Q1 | 9.76 Billion INR | 161.34% |
| 2012 FY | 39.49 Billion INR | 30.15% |
| 2012 Q2 | 15.56 Billion INR | 59.35% |
| 2011 Q2 | 12.76 Billion INR | 0.0% |
| 2011 Q4 | 3.73 Billion INR | -59.86% |
| 2011 Q3 | 9.31 Billion INR | -27.03% |
| 2011 FY | 30.34 Billion INR | 1.51% |
| 2010 FY | 29.89 Billion INR | 19.17% |
| 2009 FY | 25.08 Billion INR | 31.62% |
| 2008 FY | 19.05 Billion INR | 29.15% |
| 2007 FY | 14.75 Billion INR | 28.51% |
| 2006 FY | 11.48 Billion INR | 31.01% |
| 2005 FY | 8.76 Billion INR | 15.48% |
| 2004 FY | 7.59 Billion INR | 9.13% |
| 2003 FY | 6.95 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hester Biosciences Limited | 1.27 Billion INR | -9730.88% |
| RPG Life Sciences Limited | 2.48 Billion INR | -4942.731% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -2936.689% |
| Ipca Laboratories Limited | 48.58 Billion INR | -157.72% |
| Aarti Drugs Limited | 8.31 Billion INR | -1405.627% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -2047.204% |
| Albert David Limited | 1.4 Billion INR | -8792.277% |
| Alembic Limited | 1 Billion INR | -12419.76% |
| Alkem Laboratories Limited | 52.29 Billion INR | -139.423% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -367.542% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -27592.175% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -8407.303% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -997994.859% |
| Brooks Laboratories Limited | 65.62 Million INR | -190712.252% |
| Eris Lifesciences Limited | 10.42 Billion INR | -1100.859% |
| FDC Limited | 6.58 Billion INR | -1801.109% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -907.087% |
| Gufic Biosciences Limited | 4.07 Billion INR | -2973.618% |
| Hikal Limited | 5.95 Billion INR | -2001.561% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -2929.384% |
| Ind-Swift Limited | 2.17 Billion INR | -5663.37% |
| Innova Captab Limited | 3.46 Billion INR | -3514.177% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -2553.281% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -19086.779% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -537.433% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -20079.797% |
| Laurus Labs Limited | 15.44 Billion INR | -710.495% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -6535.924% |
| Lupin Limited | 125.09 Billion INR | -0.092% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -18015.201% |
| Medico Remedies Limited | 262.14 Million INR | -47664.206% |
| Morepen Laboratories Limited | 6.16 Billion INR | -1932.223% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -2495.967% |
| Orchid Pharma Limited | 2.32 Billion INR | -5296.321% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -2065.756% |
| Sigachi Industries Limited | 2 Billion INR | -6153.412% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 7661.507% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 51.56% |
| Themis Medicare Limited | 2.42 Billion INR | -5073.993% |
| Unichem Laboratories Limited | 4.86 Billion INR | -2473.747% |
| Vaishali Pharma Limited | 90.32 Million INR | -138525.821% |
| Venus Remedies Limited | 2.18 Billion INR | -5636.821% |
| Wanbury Limited | 1.73 Billion INR | -7134.941% |
| Windlas Biotech Limited | 1.33 Billion INR | -9252.48% |
| ZIM Laboratories Limited | 1.26 Billion INR | -9776.141% |
| Sakar Healthcare Limited | 699.58 Million INR | -17797.897% |
| Aurobindo Pharma Limited | 109.54 Billion INR | -14.302% |
| Divi's Laboratories Limited | 32.44 Billion INR | -285.977% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -1912.165% |
| Mankind Pharma Limited | 42.19 Billion INR | -196.73% |
| Sequent Scientific Limited | 2.97 Billion INR | -4103.503% |
| Neuland Laboratories Limited | 8.24 Billion INR | -1418.107% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -720.576% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | -80.574% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -5879.407% |
| Wockhardt Limited | 7.72 Billion INR | -1521.904% |
| Bal Pharma Limited | 770.19 Million INR | -16157.052% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 23.468% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -3288.261% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -23563.293% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -1260.028% |
| Shilpa Medicare Limited | 3.56 Billion INR | -3415.29% |
| Valiant Laboratories Limited | 138.02 Million INR | -90613.546% |
| Ajanta Pharma Limited | 21.06 Billion INR | -494.431% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -110677.765% |
| Granules India Limited | 16.79 Billion INR | -645.336% |
| Medicamen Biotech Limited | 495.49 Million INR | -25169.882% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -22278.968% |
| Piramal Enterprises Limited | 8.04 Billion INR | -1456.712% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -167.789% |
| NATCO Pharma Limited | 25.73 Billion INR | -386.521% |
| Suven Life Sciences Limited | -200.79 Million INR | 62457.007% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 115239.728% |
| Strides Pharma Science Limited | 14.38 Billion INR | -770.239% |
| Indoco Remedies Limited | 8.04 Billion INR | -1456.77% |
| Alpa Laboratories Limited | 188.89 Million INR | -66186.032% |
| Lasa Supergenerics Limited | 121.02 Million INR | -103354.516% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -31917.869% |